Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 73,600 shares, an increase of 429.5% from the December 31st total of 13,900 shares. Based on an average trading volume of 124,100 shares, the short-interest ratio is presently 0.6 days.
Bioasis Technologies Price Performance
BIOAF stock traded down $0.01 during trading on Monday, hitting $0.04. 213,800 shares of the company's stock were exchanged, compared to its average volume of 66,456. The business has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.11. Bioasis Technologies has a 52-week low of $0.02 and a 52-week high of $0.25.
Get
Bioasis Technologies alerts:
Bioasis Technologies (OTCMKTS:BIOAF – Get Rating) last posted its earnings results on Friday, October 28th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.09 million during the quarter. Equities research analysts anticipate that Bioasis Technologies will post -0.03 earnings per share for the current fiscal year.
Bioasis Technologies Company Profile
(Get Rating)
Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.
Featured Articles
- Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
- 4 High-Yield Dividend Kings For 2023
- Will 2023 be a Good Year for Goodyear Tire Stock?
- Lululemon Stock, Buying Opportunity on Lowered Guidance?
- Is Delta On Track To Hit A Fresh 52-Week High?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
生物綠洲科技公司(BiOASIS Technologies Inc.)是1月份空頭股數大幅增長的目標。截至15日，空頭股數共有73,600股，比12月31日的13,900股增加了429.5%。以平均成交量124,100股計算，目前短息比為0.6天。
BiOASIS技術性價比
在週一的交易中，BIOAF的股價下跌了0.01美元，達到0.04美元。該公司股票成交量為213,800股，而其平均成交量為66,456股。該業務的50日移動均線價格為0.08美元，200日移動均線價格為0.11美元。BiOasis Technologies的52周低點為0.02美元，52周高位為0.25美元。
到達
BiOASIS技術警報：
BiOasis Technologies(OTCMKTS：BIOAF-GET Rating)最近一次公佈財報是在10月28日(星期五)。該公司公佈了本季度每股收益(0.01美元)。該公司本季度的收入為90萬美元。股票研究分析師預計，BiOasis Technologies本財年的每股收益將為0.03美元。
BiOASIS技術公司簡介
(獲取評級)
BiOASIS技術公司是一家處於發展階段的生物製藥公司，致力於神經疾病和障礙的診斷和治療產品的研究和開發。它正在開發xB3，這是一種通過血腦屏障(BBB)運輸治療劑的平臺技術；以及治療中樞神經系統疾病(CNS)，包括腦癌，以及代謝和神經退行性疾病。
專題文章
- 免費獲取StockNews.com關於BiOASIS技術的研究報告(BIOAF)
- 2023年4大高收益股利之王
- 2023年對固特異輪胎庫存來說會是一個好年份嗎？
- Lululemon股票，買入機會對下調指引？
- 達美航空有望創下52周新高嗎？
- 你應該把這些沃倫·巴菲特的股票加入你的投資組合嗎？
接受《BiOASIS技術日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收最新新聞和分析師對BiOasis Technologies及相關公司的評級的每日摘要。
